Press releases
LinKinVax has the trust of world-class partners and investors.
Our last Press releases
May 20, 2022
LinKinVax puts together a highly experienced team from the world of biopharmaceuticals to lead the clinical development and upscaling of its vaccine platform
May 4, 2022
LinKinVax appoints Dr Jiong Ma as independent board member
March 15, 2022
LinKinVax announces a collaboration with GTP Bioways for the development and production of its second-generation vaccine against SARS-CoV-2
February 10, 2022
LINKINVAX raises €4.350 million in funding
To accelerate the developpement of its innovative vaccine platform
February 3, 2022
LINKINVAX and INSERM TRANSFERT enter into an exclusive woldwild licensing agreement
Covering use of an innovative vaccine platform.
June 21, 2021
Biotech start-up LinKinvax is created to accelerate the development, clinical trial and market access of a unique and innovative vaccine platform
Biotech start-up LinKinvax is created to accelerate the development, clinical trial and market access of a unique and innovative vaccine platform
May 26, 2021
LinKinVax-Labex VRI consortium secures 31 M€ in public funding to develop a booster vaccine against COVID-19
LinKinVax-Labex VRI consortium secures 31 M€ in public funding to develop a booster vaccine against COVID-19